Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia.
Beyazit
Yavuz
Y
Aksu
Salih
S
Kekilli
Murat
M
Haznedaroglu
Ibrahim C
IC
Kilickap
Sadettin
S
Goker
Hakan
H
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D001772:Blood Cell Count; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D010996:Pleural Effusion / Q000139:chemically induced / Q000000981:diagnostic imaging; D011743:Pyrimidines / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate